Shi-Qi Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shi-Qi Lin has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Lei Zhang
Center for Plastic & Reconstructive Surgery, Department of Plastic & Reconstructive Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital)
1 shared publication - Li-Li Wang
Center for Plastic & Reconstructive Surgery, Department of Plastic & Reconstructive Surgery, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College , Hangzhou, Zhejiang 310014
1 shared publication - Miao-Yun Jiang
Hangzhou Normal University
1 shared publication - Qiang Jin
Center for Plastic & Reconstructive Surgery, Department of Plastic & Reconstructive Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital)
1 shared publication - Sufan Wu
Center for Plastic and Reconstructive Surgery,Department of Plastic and Reconstructive Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, China
1 shared publication - Ting Li
Center for Plastic & Reconstructive Surgery, Department of Plastic & Reconstructive Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital)
1 shared publication
Latest Publications
- Open Access
- 29 December 2025
- Published by American Chemical Society (ACS) in ACS Polymers Au
- Vol. 6 (1) , 164-180
A Dual-Network Injectable Hydrogel Scaffold Integrating Glycyrrhizic Acid and Acellular Fat Extracts for Synergistic Enhancement of Diabetic Wound Healing
Chronic inflammation is a hallmark of diabetic wounds, severely disrupting the physiological healing cascade. Modulating this inflammatory microenvironment while ensuring biocompatibility remains a major challenge in regenerative medicine. Herein, we report the development of a multifunctional dual-network injectable hydrogel, incorporating glycyrrhizic acid (GA) and acellular fat extracts (FE), designed to enhance diabetic wound repair. The hydrogel comprises two interpenetrating networks: A reversible, dynamic network formed via Zn2+-coordinated GA confers excellent injectability and conformability, allowing tight adherence to irregular wound topographies. A secondary, physically cross-linked network is introduced by ultraviolet (UV)-induced polymerization of methacrylated hyaluronic acid (HAMA), which significantly reinforces mechanical strength and structural stability. GA exhibits inherent immunomodulatory activity, promoting macrophage polarization from the pro-inflammatory M1 phenotype to the reparative M2 phenotype, thereby attenuating local inflammation. Concurrently, FE provides a rich reservoir of pro-angiogenic and regenerative bioactive factors that synergistically promote neovascularization and tissue remodeling. In vitro and in vivo evaluations confirmed that this composite hydrogel accelerates wound closure, reduces inflammatory cytokine expression, enhances angiogenesis, and promotes granulation tissue formation. Collectively, this injectable, immunomodulatory, and pro-regenerative hydrogel platform offers a promising therapeutic strategy for the effective management of recalcitrant diabetic wounds.
- 29 December 2025
- Published by American Chemical Society (ACS) in ACS Polymers Au
- Vol. 6 (1) , 164-180
Open AccessA Dual-Network Injectable Hydrogel Scaffold Integrating Glycyrrhizic Acid and Acellular Fat Extracts for Synergistic Enhancement of Diabetic Wound Healing
Chronic inflammation is a hallmark of diabetic wounds, severely disrupting the physiological healing cascade. Modulating this inflammatory microenvironment while ensuring biocompatibility remains a major challenge in regenerative medicine. Herein, we report the development of a multifunctional dual-network injectable hydrogel, incorporating glycyrrhizic acid (GA) and acellular fat extracts (FE), designed to enhance diabetic wound repair. The hydrogel comprises two interpenetrating networks: A reversible, dynamic network formed via Zn2+-coordinated GA confers excellent injectability and conformability, allowing tight adherence to irregular wound topographies. A secondary, physically cross-linked network is introduced by ultraviolet (UV)-induced polymerization of methacrylated hyaluronic acid (HAMA), which significantly reinforces mechanical strength and structural stability. GA exhibits inherent immunomodulatory activity, promoting macrophage polarization from the pro-inflammatory M1 phenotype to the reparative M2 phenotype, thereby attenuating local inflammation. Concurrently, FE provides a rich reservoir of pro-angiogenic and regenerative bioactive factors that synergistically promote neovascularization and tissue remodeling. In vitro and in vivo evaluations confirmed that this composite hydrogel accelerates wound closure, reduces inflammatory cytokine expression, enhances angiogenesis, and promotes granulation tissue formation. Collectively, this injectable, immunomodulatory, and pro-regenerative hydrogel platform offers a promising therapeutic strategy for the effective management of recalcitrant diabetic wounds.